`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., WATSON LABORATORIES, INC., DR. REDDY’S LABORATORIES,
`INC., DR. REDDY’S LABORATORIES, LTD., and SUN
`PHARMACEUTICALS INDUSTRIES LTD.
`Petitioner,
`
`v.
`
`MERCK SHARP & DOHME CORP.
`Patent Owner.
`_________________________
`
`Case IPR2020-00040
`U.S. Patent 7,326,708 B2
`___________________________
`
`Case No. IPR2020-000401
`U.S. Patent No. 7,326,708
`__________________
`
`JOINT NOTICE OF STIPULATION TO ADJUST SCHEDULE
`
`1 Teva Pharmaceuticals USA, Inc. and Watson Laboratories, Inc. were
`joined as a party to this proceeding via Motion for Joinder in IPR2020-
`01045; Dr. Reddy’s Laboratories, Inc. and Dr. Reddy’s Laboratories, Ltd.
`were joined as a party to this proceeding via a Motion for Joinder in
`IPR2020-01060; and Sun Pharmaceuticals Industries Ltd. was joined as a
`party to this proceeding via Motion for Joinder in IPR2020-01072.
`
`US_145969051v1_391026-00257 9/25/2020 10:59 AM
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`Pursuant to the authorization provided in the original Scheduling Order
`
`(Paper 22 at 7), Petitioner hereby provides notice that Petitioner and Patent Owner
`
`have stipulated and agreed to extend Due Dates 2 and 3 as shown below. All other
`
`remaining dates remain unchanged.2
`
`Due Date No.
`Due Date 2:
`
`Current Due Date
`November 13, 2020
`
`Stipulated Due Date
`November 17, 2020
`
`Petitioner’s Reply to
`Patent Owner’s Response
`to Petition
`
`Due Date 3:
`
`December 18, 2020
`
`December 22, 2020
`
`Patent Owner’s Sur-reply
`to Petitioner’s Reply
`
`Date: September 25, 2020
`
`Respectfully submitted,
`
`/s/ Jitendra Malik/
`Jitendra Malik, Ph.D. (Reg. No. 55,823)
`Alissa M. Pacchioli (Reg. No. 74,252)
`Christopher D. West, Ph.D. (Reg. No.
`74,724)
`Heike S. Radeke, Ph.D. (Reg. No.
`75,394)
`Lance Soderstrom (Reg. No. 65,405)
`KATTEN MUCHIN ROSENMAN
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`jitty.malik@katten.com
`alissa.pacchioli@katten.com
`
`2 See Amended Schedule Order, Paper 39 providing remaining dates.
`2
`
`US_145969051v1_391026-00257 9/25/2020 10:59 AM
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`christopher.west@katten.com
`heike.radeke@katten.com
`lance.soderstrom@katten.com
`Counsel for Petitioner
`Mylan Pharmaceuticals Inc.
`
`/s/ Stanley E. Fisher/
`Stanley E. Fisher (Reg. No. 55,820)
`Bruce R. Genderson (Pro Hac Vice)
`Jessamyn S. Berniker (Reg. No. 72,328)
`Alexander S. Zolan (Pro Hac Vice)
`Elise M. Baumgarten (Pro Hac Vice)
`Shaun P. Mahaffy (Reg. No. 75,534)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`sfisher@wc.com
`bgenderson@wc.com
`jberniker@wc.com
`azolan@wc.com
`ebaumgarten@wc.com
`smahaffy@wc.com
`asheh@wc.com
`
`Counsel for Patent Owner
`Merck Sharp & Dohme Corp.
`
`US_145969051v1_391026-00257 9/25/2020 10:59 AM
`
`3
`
`
`
`Case No. IPR2020-00040
`U.S. Patent No. 7,326,708
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy of the foregoing paper was served on September 25, 2020, by
`
`delivering a copy via electronic mail on the following attorneys of record:
`
`kzullow@goodwinprocter.com
`
`sfischer@goodwinprocter.com
`
`erapalino@goodwinlaw.com
`
`sfisher@wc.com
`
`jberniker@wc.com
`
`smahaffy@wc.com
`
`asheh@wc.com,
`
`bgenderson@wc.com
`
`ebaumgarten@wc.com
`
`azolan@wc.com
`
`jwong@winston.com
`
`rfaegenburg@lernerdavid.com
`
`ZCohen@winston.com
`
`tvanbuskirk@lernerdavid.com
`
`CKlein@winston.com
`
`mteschner@lernerdavid.com
`
`Cfundakowski@winston.com
`
`/s/ Jitendra Malik/
`
`Jitendra Malik, Ph.D. (Reg. No. 55,823)
`
`US_145969051v1_391026-00257 9/25/2020 10:59 AM
`
`4
`
`